Pharmacological Properties of Faster-Acting Insulin Aspart
Sign Up to like & getrecommendations! Published in 2017 at "Current Diabetes Reports"
DOI: 10.1007/s11892-017-0931-y
Abstract: Purpose of ReviewFaster aspart is a new formulation of insulin aspart (IAsp) produced by adding the excipients niacinamide and L-arginine. As this new, “ultra-rapid insulin” is available in the EU-market and Canada, the pharmacokinetic and… read more here.
Keywords: insulin; pharmacological properties; insulin aspart; faster aspart ... See more keywords
Effect of ultra-rapid insulin aspart on glycemic control in children with type 1 diabetes: the experience of a Portuguese tertiary centre
Sign Up to like & getrecommendations! Published in 2022 at "Diabetology international"
DOI: 10.1007/s13340-021-00565-8
Abstract: Postprandial hyperglycemia is one of the biggest challenges in children with type 1 diabetes (T1D). Ultra-fast-acting aspartic insulin (faster aspart) has a quicker onset of action and an earlier maximum activity. The aim of this… read more here.
Keywords: faster aspart; type diabetes; insulin; control children ... See more keywords
[The impact of «faster aspart» on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pump].
Sign Up to like & getrecommendations! Published in 2020 at "Anales de pediatria"
DOI: 10.1016/j.anpedi.2020.11.002
Abstract: BACKGROUND AND AIMS Post-prandial glucose control is essential to achieve metabolic goals in patients with type 1 diabetes mellitus (T1DM). The new «faster aspart» insulin has a pharmacological profile noted for its faster absorption and… read more here.
Keywords: insulin; sensor augmented; faster aspart; sensor ... See more keywords
Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective.
Sign Up to like & getrecommendations! Published in 2019 at "Canadian journal of diabetes"
DOI: 10.1016/j.jcjd.2019.01.004
Abstract: Limiting postprandial glucose (PPG) excursions is an important aspect of overall glycemic control. Rapid-acting insulin analogues (RAIAs) aim to mimic the physiologic action of endogenous insulin observed in individuals without diabetes and prevent excessive PPG… read more here.
Keywords: insulin; insulin analogues; type diabetes; insulin aspart ... See more keywords
Biosimilars and Novel Insulins.
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001079
Abstract: BACKGROUND Insulin therapy is the mainstay of treatment for type 1 diabetes and may be necessary in type 2 diabetes. Current insulin analogues present a more physiological profile, are effective, and with less risk of… read more here.
Keywords: biosimilar insulins; insulin; insulin aspart; faster aspart ... See more keywords
Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Diabetes Science and Technology"
DOI: 10.1177/1932296817730375
Abstract: Background: Ultra-fast-acting insulins, such as fast-acting insulin aspart (faster aspart), have pharmacokinetic properties that may be advantageous for patients using continuous subcutaneous insulin infusion (CSII), provided that they are compatible with and safe to use… read more here.
Keywords: infusion; faster aspart; insulin aspart; fast acting ... See more keywords
Efficacy and safety of fast-acting insulin aspart versus insulin aspart in children and adolescents with type 1 diabetes from Japan.
Sign Up to like & getrecommendations! Published in 2021 at "Endocrine journal"
DOI: 10.1507/endocrj.ej20-0116
Abstract: The aim of this post-hoc subgroup analysis, which was based on data from the treat-to-target, 26-week, onset 7 trial, was to confirm the efficacy and safety of fast-acting insulin aspart (faster aspart) versus insulin aspart… read more here.
Keywords: insulin aspart; faster aspart; children adolescents; aspart versus ... See more keywords
Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes Care"
DOI: 10.2337/dc21-0814
Abstract: OBJECTIVE To evaluate glucose control using fast-acting insulin aspart (faster aspart) compared with insulin aspart (IAsp) delivered by the MiniMed Advanced Hybrid Closed-Loop (AHCL) system in adults with type 1 diabetes. RESEARCH DESIGN AND METHODS… read more here.
Keywords: aspart; insulin aspart; type diabetes; faster aspart ... See more keywords